Ingeborg Hammen

Title: **Ingeborg Hammen: Pioneering Innovations in Pharmaceutical Chemistry**

Introduction

Ingeborg Hammen, a distinguished inventor based in Cologne, Germany, has made significant contributions to the field of pharmaceutical chemistry. With her expertise and innovative spirit, she has earned recognition for her work on specialized compounds that have the potential to impact various applications in medicine and technology.

Latest Patents

Ingeborg Hammen holds one patent, which focuses on a novel class of compounds. Specifically, her patent titled "O-alkyl-S-[1,6-dihydro-6-oxo-pyridazin(1)ylmethyl]-(thiono)-(di)-thiolphosphoric (phosphonic) acid esters" highlights the chemical formula involving R1 as an alkyl or alkoxyalkyl with 1 to 6 carbon atoms per alkyl chain. This innovative work aims to advance drug development and improve therapeutic outcomes.

Career Highlights

Hammen is currently employed at Bayer Aktiengesellschaft, a leading global life sciences company. Her career reflects a strong commitment to research and innovation within the pharmaceutical sector. With her extensive knowledge and experience, she continues to contribute meaningfully to Bayer's objectives and the broader scientific community.

Collaborations

Throughout her career, Ingeborg has had the opportunity to collaborate with esteemed colleagues, including Wolfgang Hofer and Fritz Maurer. These collaborations have fostered a dynamic exchange of ideas and have been pivotal in driving forward important research initiatives within the company.

Conclusion

Ingeborg Hammen's work exemplifies the essence of innovation in pharmaceutical chemistry. Through her patent and collaborations, she not only enhances the field but also serves as an inspiration to aspiring inventors in the industry. As a key player at Bayer Aktiengesellschaft, she continues to shape the future of medicine with her groundbreaking contributions.